ES2149466T3 - Vacunas de chlamydia. - Google Patents

Vacunas de chlamydia.

Info

Publication number
ES2149466T3
ES2149466T3 ES96912001T ES96912001T ES2149466T3 ES 2149466 T3 ES2149466 T3 ES 2149466T3 ES 96912001 T ES96912001 T ES 96912001T ES 96912001 T ES96912001 T ES 96912001T ES 2149466 T3 ES2149466 T3 ES 2149466T3
Authority
ES
Spain
Prior art keywords
chlamydia vaccines
chlamydia
vaccines
stimulants
immuno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96912001T
Other languages
English (en)
Inventor
Jean-Paul Prieels
Moncef Mohamed Slaoui
Jean-Francois Uni Maisonneuve
Vincent Uni Des Scienc Verlant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Application granted granted Critical
Publication of ES2149466T3 publication Critical patent/ES2149466T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA UNA NUEVA VACUNA PARA LA PREVENCION DE LAS INFECCIONES POR CLAMIDIA EMPLEANDO LA PROTEINA DE MEMBRANA EXTERNA Y DOS INMUNOESTIMULANTES, 3D
ES96912001T 1995-04-03 1996-04-01 Vacunas de chlamydia. Expired - Lifetime ES2149466T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9506863.1A GB9506863D0 (en) 1995-04-03 1995-04-03 Vaccines

Publications (1)

Publication Number Publication Date
ES2149466T3 true ES2149466T3 (es) 2000-11-01

Family

ID=10772426

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96912001T Expired - Lifetime ES2149466T3 (es) 1995-04-03 1996-04-01 Vacunas de chlamydia.

Country Status (22)

Country Link
EP (1) EP0820304B1 (es)
JP (2) JPH11503142A (es)
KR (1) KR19980703666A (es)
CN (1) CN1185740A (es)
AT (1) ATE193974T1 (es)
AU (1) AU700548B2 (es)
BR (1) BR9604853A (es)
CA (1) CA2215520C (es)
CZ (1) CZ313497A3 (es)
DE (1) DE69608959T2 (es)
DK (1) DK0820304T3 (es)
ES (1) ES2149466T3 (es)
GB (1) GB9506863D0 (es)
GR (1) GR3033764T3 (es)
HU (1) HUP9801572A3 (es)
NO (1) NO974561L (es)
NZ (1) NZ306443A (es)
PL (1) PL322620A1 (es)
PT (1) PT820304E (es)
TR (1) TR199701113T1 (es)
WO (1) WO1996031236A1 (es)
ZA (1) ZA962616B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9626864D0 (en) * 1996-12-24 1997-02-12 Smithkline Beecham Biolog Vaccine
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US6306404B1 (en) 1998-07-14 2001-10-23 American Cyanamid Company Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB9819898D0 (en) * 1998-09-11 1998-11-04 Smithkline Beecham Plc New vaccine and method of use
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6635261B2 (en) 1999-07-13 2003-10-21 Wyeth Holdings Corporation Adjuvant and vaccine compositions containing monophosphoryl lipid A
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
BRPI0609547A2 (pt) * 2005-03-31 2011-10-18 Glaxosmithkline Biolog Sa composição, uso de uma composição, método para o tratamento ou prevenção de infecção por chlamydia, uso de uma ou mais proteìnas de chlamydia, de fragmentos imunogênicos das mesmas ou de polinucleotìdeos codificando os mesmos, método para o tratamento ou prevenção de infecção por chlamydia, e, método para a determinação prévia de infecção por chlamydia em um indivìduo
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用
CN113940994B (zh) * 2021-11-09 2023-09-15 南华大学 壳聚糖-Pickering乳液白细胞介素12佐剂体系的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9000207A (es) * 1990-01-29 1991-08-16 Duphar Int Res
EP0562020A4 (en) * 1990-12-10 1993-11-18 Alving, Carl L. A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis
CH682455A5 (fr) * 1991-07-25 1993-09-30 Serge Liotet Composition vaccinale.
JPH05339169A (ja) * 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
CA2138997C (en) * 1992-06-25 2003-06-03 Jean-Paul Prieels Vaccine composition containing adjuvants

Also Published As

Publication number Publication date
BR9604853A (pt) 1998-06-16
PL322620A1 (en) 1998-02-02
ATE193974T1 (de) 2000-07-15
PT820304E (pt) 2000-11-30
EP0820304B1 (en) 2000-06-21
NZ306443A (en) 1999-02-25
KR19980703666A (ko) 1998-12-05
CA2215520C (en) 2008-01-22
HUP9801572A2 (hu) 1998-10-28
MX9707638A (es) 1998-06-28
JP2007308508A (ja) 2007-11-29
WO1996031236A1 (en) 1996-10-10
EP0820304A1 (en) 1998-01-28
NO974561D0 (no) 1997-10-02
CZ313497A3 (cs) 1998-03-18
HUP9801572A3 (en) 1999-04-28
DE69608959D1 (de) 2000-07-27
CA2215520A1 (en) 1996-10-10
TR199701113T1 (xx) 1998-03-21
DK0820304T3 (da) 2000-08-28
GB9506863D0 (en) 1995-05-24
AU5499996A (en) 1996-10-23
CN1185740A (zh) 1998-06-24
HK1008495A1 (en) 1999-05-14
NO974561L (no) 1997-11-26
AU700548B2 (en) 1999-01-07
DE69608959T2 (de) 2000-11-16
ZA962616B (en) 1996-11-27
GR3033764T3 (en) 2000-10-31
JPH11503142A (ja) 1999-03-23

Similar Documents

Publication Publication Date Title
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
DE69519041D1 (de) Dna-impfstoffe gegen rotavirusinfektionen
PT1326635E (pt) Composicao farmaceutica para imunizacao contra a sida
DE122005000024I1 (de) Darifenacin enthaltende Pharmazeutische Zubereitungen.
FI946064A0 (fi) Apuaineita sisältävä rokotekoostumus
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
NO991524L (no) Vaksiner
ES2128761T3 (es) Formulacion de tirilazad con cosolvente para administracion parenteral.
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
DK0820304T3 (da) Chlamydia-vacciner
FI20070041L (fi) Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
MX9206000A (es) Vacuna contra la dermatomicosis y procedimiento para su preparacion.
FI973184A7 (fi) Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibi ittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdoll isesti yhdessä AZT:n, DDI:n tai DDC:n kanssa
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
EP1017409A4 (en) VACCINES FOR CHLAMYDIA PSITTACI INFECTIONS
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
DE59608611D1 (de) Topische aciclovir-zubereitung
FI970933A7 (fi) Entraalinen rokote vaginaalisia infektioita vastaan
IT8919025A0 (it) Quadro di tessitura di configurazione asimmetrica.
MX9101421A (es) Composiciones farmaceuticas que comprenden naproxen y sodio de naproxen e hidrocloruro de pseudoefedrina.
ITRM910384A0 (it) Procedimento di preparazione di vaccini anti-influenzali e vaccini conesso ottenuti.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 820304

Country of ref document: ES